
Comera Life Sciences
Enhancing therapeutic protein formulations for better patient experience and extended product lifecycle.
Market cap
$6.2k
Enterprise value
($2m)
Share price
$0.00 CMRA
Authorizing premium user...
Enhancing therapeutic protein formulations for better patient experience and extended product lifecycle.